117 related articles for article (PubMed ID: 23250314)
1. [Evaluating the usefulness of a breast screening program in Bogotá, Colombia].
González-Mariño MA
Rev Salud Publica (Bogota); 2012; 14(1):41-52. PubMed ID: 23250314
[TBL] [Abstract][Full Text] [Related]
2. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
3. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
5. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Schiller-Fruehwirth I; Jahn B; Einzinger P; Zauner G; Urach C; Siebert U
Value Health; 2017 Sep; 20(8):1048-1057. PubMed ID: 28964436
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
Tina Shih YC; Dong W; Xu Y; Shen Y
Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
[No Abstract] [Full Text] [Related]
8. Personalized Mammography Screening and Screening Adherence-A Simulation and Economic Evaluation.
Arnold M; Quante AS
Value Health; 2018 Jul; 21(7):799-808. PubMed ID: 30005752
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
10. Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.
Comas M; Arrospide A; Mar J; Sala M; Vilaprinyó E; Hernández C; Cots F; Martínez J; Castells X
PLoS One; 2014; 9(5):e97459. PubMed ID: 24832200
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the Norwegian breast cancer screening program.
van Luijt PA; Heijnsdijk EA; de Koning HJ
Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer screening; cost-effective in practice?
De Koning HJ
Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance target for community-based breast cancer screening in China: a model simulation.
Yang L; Wang J; Cheng J; Wang Y; Lu W
BMC Cancer; 2018 Mar; 18(1):261. PubMed ID: 29514679
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
16. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
Carter KJ; Castro F; Morcos RN
AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
[TBL] [Abstract][Full Text] [Related]
17. Total cost-effectiveness of mammography screening strategies.
Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis for breast cancer screening: double reading versus single + CAD reading.
Sato M; Kawai M; Nishino Y; Shibuya D; Ohuchi N; Ishibashi T
Breast Cancer; 2014 Sep; 21(5):532-41. PubMed ID: 23104393
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]